0002140719-26-000005.txt : 20260807 0002140719-26-000005.hdr.sgml : 20260807 20260807105106 ACCESSION NUMBER: 0002140719-26-000005 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260807 DATE AS OF CHANGE: 20260807 EFFECTIVENESS DATE: 20260807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioGene Therapeutics Inc. CENTRAL INDEX KEY: 0002140719 ORGANIZATION NAME: EIN: 352875404 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-593463 FILM NUMBER: 261252291 BUSINESS ADDRESS: STREET 1: 5900 BALCONES DR, STE 100 CITY: AUSTIN STATE: TX ZIP: 78731 BUSINESS PHONE: 1-512-379-7526 MAIL ADDRESS: STREET 1: 5900 BALCONES DR, STE 100 CITY: AUSTIN STATE: TX ZIP: 78731 D 1 primary_doc.xml X0708 D LIVE 0002140719 BioGene Therapeutics Inc. 5900 BALCONES DR, STE 100 AUSTIN TX TEXAS 78731 1-512-379-7526 TEXAS None None Corporation true 2024 STEPHEN VAN DEVENTER 5900 BALCONES DR, STE 100 AUSTIN TX TEXAS 78731 Executive Officer Director DEEPAK SAMPATH 5900 BALCONES DR, STE 100 AUSTIN TX TEXAS 78731 Director PATROSKI LAWSON 5900 BALCONES DR, STE 100 AUSTIN TX TEXAS 78731 Director STEVE GLOVER 5900 BALCONES DR, STE 100 AUSTIN TX TEXAS 78731 Director RAJ PRUTHI 5900 BALCONES DR, STE 100 AUSTIN TX TEXAS 78731 Director DAVID TYRONNE HOWTON 5900 BALCONES DR, STE 100 AUSTIN TX TEXAS 78731 Director Biotechnology Decline to Disclose 06b false 2026-06-05 false true true false 0 3000000 3000000 0 Consists of the grant of 100,000 stock options and 500,000 restricted share units and the underlying shares. false 1 0 0 0 false BioGene Therapeutics Inc. /s/ Stephen Van Deventer Stephen Van Deventer CEO 2026-08-06